100 Clinical Results associated with AuRx, Inc.
0 Patents (Medical) associated with AuRx, Inc.
01 Jan 2004·Clinical and diagnostic laboratory immunology
Performance and Use of a Ribonucleotide Reductase Herpes Simplex Virus Type-Specific Serological Assay
Article
Author: Wachsman, M. ; Aurelian, L. ; Wales, S. Q. ; Smith, C. C. ; Calton, G.
ABSTRACT:In response to the increasingly evident need for herpes simplex virus (HSV) serotype-specific serologic assays that rely on proteins other than glycoprotein-G (gG), we developed a rapid serologic assay that is based on type-specific epitopes within the large subunit of HSV ribonucleotide reductase (R1). The assay (Au-2 enzyme-linked immunosorbent assay [ELISA]) uses an HSV type 2 (HSV-2) R1 peptide antigen. It provides a reliable method for detecting serotype-specific antibody to a protein other than gG-2. The Au-2 ELISA has high sensitivity and specificity as determined by direct comparison to Western blotting, a widely accepted “gold standard,” and to ELISA with an HSV-1 R1 peptide (Au-1). The use of the Au-2 ELISA in conjunction with the gG-2-based assays will improve the sensitivity and specificity of serologic diagnosis and patient management.
100 Deals associated with AuRx, Inc.
100 Translational Medicine associated with AuRx, Inc.